ArticleClinical rheumatology2025

Risk factors of cytomegalovirus reactivation in patients with rheumatic musculoskeletal diseases undergoing remission induction therapy with high-dose glucocorticoids; a prospective short-term cohort study.

Yuichiro Ota et al.PubMed ↗Publisher ↗

No numbers read from the abstract.